4-azole substituted imidazole compositions useful as inhibitors or c-Met receptor tyrosine kinase

Details for Australian Patent Application No. 2004284420 (hide)

Owner Vertex Pharmceuticals Incorporated

Inventors Li, Pan; Tomlinson, Ronald C.; Aronov, Alex; Lauffer, David J.

Agent Cullen & Co

Pub. Number AU-A-2004284420

PCT Pub. Number WO2005/040345

Priority 60/505,634 24.09.03 US

Filing date 24 September 2004

Wipo publication date 6 May 2005

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040345 Priority application(s): WO2005/040345

27 April 2006 Change of Name(s) of Applicant(s), Section 104

  Vertex Pharmceuticals Incorporated, Has no value - Entry Incomplete The name of the applicant has been changed to Vertex Pharmaceuticals Incorporated 2005

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284423-Interior wallboard and method of making same

2004284412